Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
収録刊行物
-
- Ann Oncol
-
Ann Oncol 18 510-517, 2007